- Home
- HHS vs ANEB Comparison
HHS vs ANEB Comparison
Compare HHS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- ANEB
- Stock Information
- Founded
- HHS 1923
- ANEB 2020
- Country
- HHS United States
- ANEB United States
- Employees
- HHS N/A
- ANEB N/A
- Industry
- HHS Advertising
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- HHS Consumer Discretionary
- ANEB Health Care
- Exchange
- HHS Nasdaq
- ANEB Nasdaq
- Market Cap
- HHS 37.0M
- ANEB 39.0M
- IPO Year
- HHS N/A
- ANEB 2021
- Fundamental
- Price
- HHS $4.55
- ANEB $1.04
- Analyst Decision
- HHS
- ANEB Strong Buy
- Analyst Count
- HHS 0
- ANEB 2
- Target Price
- HHS N/A
- ANEB $5.50
- AVG Volume (30 Days)
- HHS 7.6K
- ANEB 11.7K
- Earning Date
- HHS 05-14-2025
- ANEB 05-13-2025
- Dividend Yield
- HHS N/A
- ANEB N/A
- EPS Growth
- HHS N/A
- ANEB N/A
- EPS
- HHS N/A
- ANEB N/A
- Revenue
- HHS $181,355,000.00
- ANEB N/A
- Revenue This Year
- HHS $6.54
- ANEB N/A
- Revenue Next Year
- HHS N/A
- ANEB N/A
- P/E Ratio
- HHS N/A
- ANEB N/A
- Revenue Growth
- HHS N/A
- ANEB N/A
- 52 Week Low
- HHS $4.24
- ANEB $0.80
- 52 Week High
- HHS $8.87
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- HHS 46.53
- ANEB 45.52
- Support Level
- HHS $4.53
- ANEB $1.00
- Resistance Level
- HHS $4.94
- ANEB $1.15
- Average True Range (ATR)
- HHS 0.31
- ANEB 0.08
- MACD
- HHS -0.00
- ANEB 0.01
- Stochastic Oscillator
- HHS 37.80
- ANEB 37.77
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.